Literature DB >> 9138018

Expression of the IL-2 receptor gamma subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component.

L Bani1, D David, J L Moreau, A Cayota, T Nakarai, J Ritz, J Thèze.   

Abstract

IL-2 receptor (IL-2R) is composed of three subunits named IL-2R alpha, IL-2R gamma. Here, we study the expression of the IL-2R gamma in highly purified, resting peripheral human CD4 T lymphocytes. We show by FACS analysis that the IL-2R gamma subunit is not detectable at the cell surface of peripheral CD4 T lymphocytes. This result has been verified after acid treatment of the cell surface and analysis with three specific anti-IL-2R gamma mAb. Using RT-PCR and intracellular FACS analysis, we demonstrate that IL-2R gamma is constitutively expressed at the mRNA level and the protein is stored as an intracellular component in resting CD4 T lymphocytes. IL-2R alpha and beta subunits are not detectable by these methods. In addition, we show that CD4 T cell remain insensitive to a variety of cytokines that share IL-2R gamma as a common subunit of their receptors (e.g. IL-2, IL-4, IL-7 and IL-15). The kinetics of cell surface expression of IL-2R gamma have been studied after activation of CD4 T lymphocytes and compared with induction of IL-2R alpha and IL-2R beta. Maximum expression of IL-2R gamma is observed after 2 days of stimulation, and remains constant and comparable to IL-2R beta up to day 5. We conclude from these studies that IL-2R gamma is translocated to the membrane only after T cell activation and induction of the IL-2R alpha and IL-2R beta genes. We hypothesize that in CD4 T cells a large intracellular pool of IL-2R gamma is present but that its cell surface translocation depends on the expression of alpha and/or beta chains specific for IL-2, IL-4, IL-7, IL-9 or IL-15.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138018     DOI: 10.1093/intimm/9.4.573

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

Review 1.  Role of IL-2 in cancer immunotherapy.

Authors:  Tao Jiang; Caicun Zhou; Shengxiang Ren
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

Review 2.  The common γ-chain cytokine receptor: tricks-and-treats for T cells.

Authors:  Adam T Waickman; Joo-Young Park; Jung-Hyun Park
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

3.  Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy.

Authors:  D David; L Bani; J L Moreau; M P Treilhou; T Nakarai; M Joussemet; J Ritz; B Dupont; G Pialoux; J Thèze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

4.  Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4 T lymphocytes.

Authors:  M Kryworuchko; V Pasquier; J Thèze
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

5.  The quantal theory of how the immune system discriminates between "self and non-self"

Authors:  Kendall A Smith
Journal:  Med Immunol       Date:  2004-12-17

6.  Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes.

Authors:  Alla N Shatrova; Elena V Mityushova; Irina O Vassilieva; Nikolay D Aksenov; Valery V Zenin; Nikolay N Nikolsky; Irina I Marakhova
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

7.  CD4+ T-Cells With High Common γ Chain Expression and Disturbed Cytokine Production Are Enriched in Children With Type-1 Diabetes.

Authors:  Julia Seyfarth; Nathalie Mütze; Jennifer Antony Cruz; Sebastian Kummer; Christina Reinauer; Ertan Mayatepek; Thomas Meissner; Marc Jacobsen
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.